ES2070266T3 - Vacuna contra la infeccion por escherichia coli. - Google Patents

Vacuna contra la infeccion por escherichia coli.

Info

Publication number
ES2070266T3
ES2070266T3 ES90201990T ES90201990T ES2070266T3 ES 2070266 T3 ES2070266 T3 ES 2070266T3 ES 90201990 T ES90201990 T ES 90201990T ES 90201990 T ES90201990 T ES 90201990T ES 2070266 T3 ES2070266 T3 ES 2070266T3
Authority
ES
Spain
Prior art keywords
escherichia coli
vaccine against
against infection
toxin
coli
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90201990T
Other languages
English (en)
Spanish (es)
Inventor
Den Bosch Johannes Francis Van
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo Nobel NV
Original Assignee
Akzo Nobel NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel NV filed Critical Akzo Nobel NV
Application granted granted Critical
Publication of ES2070266T3 publication Critical patent/ES2070266T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0258—Escherichia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
ES90201990T 1989-08-18 1990-07-23 Vacuna contra la infeccion por escherichia coli. Expired - Lifetime ES2070266T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP89202110 1989-08-18

Publications (1)

Publication Number Publication Date
ES2070266T3 true ES2070266T3 (es) 1995-06-01

Family

ID=8202455

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90201990T Expired - Lifetime ES2070266T3 (es) 1989-08-18 1990-07-23 Vacuna contra la infeccion por escherichia coli.

Country Status (16)

Country Link
US (1) US5750115A (OSRAM)
EP (1) EP0413378B1 (OSRAM)
JP (1) JP3031561B2 (OSRAM)
KR (1) KR0177510B1 (OSRAM)
CN (1) CN1062605C (OSRAM)
AU (1) AU635062B2 (OSRAM)
CA (1) CA2022420C (OSRAM)
DE (1) DE69016129T2 (OSRAM)
DK (1) DK0413378T3 (OSRAM)
ES (1) ES2070266T3 (OSRAM)
GR (1) GR3015782T3 (OSRAM)
HU (2) HU210965B (OSRAM)
IL (1) IL95175A (OSRAM)
NZ (1) NZ234933A (OSRAM)
TW (1) TW204353B (OSRAM)
ZA (1) ZA906100B (OSRAM)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3871489D1 (de) * 1987-10-26 1992-07-02 Akzo Nv Impfstoff gegen e.coli-blutvergiftung bei gefluegel.
US6749831B1 (en) * 1997-05-16 2004-06-15 Medical Defense Technology, Llc Vaccine against lipopolysaccharide core
CA2289760A1 (en) * 1997-05-16 1998-11-19 Medical Defense Technologies, Llc. Vaccine against lipopolysaccharide core
BR9910438A (pt) * 1998-05-15 2001-01-02 Mkb Invest Ltd Partnership Composições e processos para imunização de aves domésticas
US8828226B2 (en) 2003-03-01 2014-09-09 The Trustees Of Boston University System for assessing the efficacy of stored red blood cells using microvascular networks
WO2007025333A1 (en) 2005-08-30 2007-03-08 Commonwealth Scientific And Industrial Research Organisation Bacterial delivery of biologically active polypeptides
US9199016B2 (en) 2009-10-12 2015-12-01 New Health Sciences, Inc. System for extended storage of red blood cells and methods of use
US11284616B2 (en) 2010-05-05 2022-03-29 Hemanext Inc. Irradiation of red blood cells and anaerobic storage
CN102711865B (zh) 2009-10-12 2015-08-19 新健康科学股份有限公司 具有氧和二氧化碳消耗能力的血液贮藏袋系统和消耗装置
NZ599890A (en) 2009-10-12 2014-03-28 Univ Pittsburgh Oxygen depletion devices and methods for removing oxygen from red blood cells
US12089589B2 (en) 2009-10-12 2024-09-17 Hemanext Inc. Irradiation of red blood cells and anaerobic storage
EP2608816B1 (en) 2010-08-25 2023-07-05 Hemanext Inc. Method for enhancing red blood cell quality and survival during storage
ES2793484T3 (es) 2010-11-05 2020-11-16 Hemanext Inc Irradiación de glóbulos rojos y almacenamiento anaeróbico
US9067004B2 (en) 2011-03-28 2015-06-30 New Health Sciences, Inc. Method and system for removing oxygen and carbon dioxide during red cell blood processing using an inert carrier gas and manifold assembly
WO2013009843A1 (en) * 2011-07-11 2013-01-17 Camas Incorporated Compositions against bacterial toxins
PT3061509T (pt) 2011-08-10 2019-09-10 New Health Sciences Inc Depleção de leucócito, oxigénio e/ou co2 integrada e dispositivo de filtro de separação de plasma
EP3967143B1 (en) 2013-02-28 2025-05-21 Hemanext Inc. Gas addition device for blood treatment and corresponding method
KR20250033333A (ko) 2015-03-10 2025-03-07 헤마넥스트 인코포레이티드 산소 감소 1회용 키트, 장치 및 이의 사용 방법
MX2017013524A (es) 2015-04-23 2018-05-22 New Health Sciences Inc Recipientes para el almacenamiento anaerobico de sangre.
BR112017024091B1 (pt) 2015-05-18 2022-09-20 Hemanext Inc Método para reduzir citocinas em um produto de sangue total armazenado, composição de sangue total armazenado e uso de um produto de sangue total armazenado
PT3463466T (pt) 2016-05-27 2022-04-04 Hemanext Inc Método de armazenamento de sangue anaeróbio e inativação de patógenos
US11260119B2 (en) 2018-08-24 2022-03-01 Pfizer Inc. Escherichia coli compositions and methods thereof
US12138302B2 (en) 2020-10-27 2024-11-12 Pfizer Inc. Escherichia coli compositions and methods thereof
US12357681B2 (en) 2020-12-23 2025-07-15 Pfizer Inc. E. coli FimH mutants and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58135819A (ja) * 1982-02-09 1983-08-12 Nisshin Flour Milling Co Ltd 鶏の大腸菌症の予防法
US4772464A (en) * 1985-08-01 1988-09-20 Miles Laboratories, Inc. Protective antibodies to serotypic determinants of flagellar antigens
US4702911A (en) 1985-09-27 1987-10-27 Immunomed Corporation Preparation of bacterium pili subunits and vaccines containing pili subunits
DE3787820T2 (de) * 1986-03-11 1994-04-28 Shionogi & Co Für Flagellin kodierende DNS und dieses enthaltender Vektor.

Also Published As

Publication number Publication date
NZ234933A (en) 1992-06-25
TW204353B (OSRAM) 1993-04-21
AU635062B2 (en) 1993-03-11
JP3031561B2 (ja) 2000-04-10
JPH03184996A (ja) 1991-08-12
KR0177510B1 (ko) 1999-03-20
HU211827A9 (en) 1995-12-28
EP0413378A1 (en) 1991-02-20
CA2022420C (en) 2000-03-28
IL95175A (en) 1994-05-30
ZA906100B (en) 1991-05-29
DK0413378T3 (da) 1995-05-15
HUT59612A (en) 1992-06-29
EP0413378B1 (en) 1995-01-18
KR910004209A (ko) 1991-03-28
CN1049523A (zh) 1991-02-27
HU210965B (en) 1995-09-28
IL95175A0 (en) 1991-06-10
DE69016129T2 (de) 1995-05-24
HU905053D0 (en) 1991-01-28
GR3015782T3 (en) 1995-07-31
AU6109990A (en) 1991-02-21
DE69016129D1 (de) 1995-03-02
CN1062605C (zh) 2001-02-28
CA2022420A1 (en) 1991-02-19
US5750115A (en) 1998-05-12

Similar Documents

Publication Publication Date Title
ES2070266T3 (es) Vacuna contra la infeccion por escherichia coli.
NO20004972L (no) Derivater av pneumokokkale kolinbindende proteiner for vaksiner
PA8549701A1 (es) Vacunacion en dosis unica con mycoplasma hyopneumoniae
CY1108147T1 (el) Εμβολιο κατα των σεξουαλικως μεταδιδομενων νοσων
FR2814958B1 (fr) Composition vaccinale
ES2160601T3 (es) Vacunas de conjugado de polisacaridos de estreptococos del grupo b tipo ii y tipo v-proteina.
PA8549801A1 (es) Vacuna de mycoplasma bovis y metodos para reducir la neumonia en animales
ES2137310T3 (es) Vacuna contra una infeccion por streptococcus suis.
CY1108178T1 (el) Βακτηριο που προκαλει νοσο των πουλερικων και εμβολιο προερχομενο εξ' αυτου
BR0006291A (pt) Bactéria do gênero salmonella, vacina para aproteção de animais contra a salmonelose, uso deuma bactéria, e, processo para a preparação deuma vacina
BR0110278A (pt) Composição de vacina, anticorpo ou anti-soro, métodos de produção de um anticorpo ou de um anti-soro e de imunização de um animal contra um ectoparasita que se alimenta de sangue, proteìna de cemento de carrapato, e, uso de uma proteìna de cemento de carrapato
BR0109928A (pt) Uso de um herpes vìrus atenuado, e, método para estimular uma resposta imune em um indivìduo humano ou animal, ou para tratar ou prevenir uma infecção patogênica ou câncer em um indivìduo humano ou animal
ES2058100T3 (es) Vacuna combinada.
PT894500E (pt) Vacina para streptococcus equi
ES2066206T3 (es) Utilizacion de adenilciclasa como vacunas contra bordetella.
AR009650A1 (es) Mycoplasma synoviae atenuado vivo, su uso, un cultivo microbiologico que lo comprende, una vacuna bacteriana atenuada viva para la proteccion de las aves de corral contra la infeccion por mycoplasma synoviae y un metodo para preparar dicha vacuna.
HUP9700975A2 (hu) Élő, legyengített, Pasteurellaceae családba tartozó, RTX-termelő baktériumok
DK0623170T3 (da) Vacciner baseret på streptokinase
BR9305075A (pt) Antígeno para conferir imunidade protetora contra infecções helmínticas em humanos e animais,e processo de vacinação para aplicação na imunoprofilaxia de doenças helmintológicas de interesse veterinário e médico
PT636030E (pt) Vacina de bacterina-toxoide de pasteurella haemolytica tipo a-1
DE60126490D1 (de) Adjuvanszusammensetzung enthaltend fha oder ein fha-fragment in freier form
NO953311D0 (no) Anvendelse av anti-helmint-vaksiner ved kontroll av parasittsykdom i forbindelse med tap av naturlig immunitet
BR0007491A (pt) Uso de 3-isoxazolidinonas e ácidos hidroxilâmicospara o tratamento de infecções
DE69833568D1 (de) Isolierte stämme von staphylococcus aureus und daraus hergestellte impfstoffe
BR0110791A (pt) Composição, métodos para induzir uma resposta imune em um indivìduo contra um imunogene, para modular o sistema imune de um indivìduo e para imunizar um indivìduo contra um patógeno, vacina recombinante, e patógeno atenuado vivo

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 413378

Country of ref document: ES